Lipigon Pharmaceuticals AB Net Asset Quality Index
Lipigon Pharmaceuticals AB net asset quality index. Lipigon Pharmaceuticals AB (LPGO) has a Net Asset Quality Index of 68.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr11.49 Million minus total liabilities of Skr3.57 Million yields net assets of Skr7.91 Million. A higher index indicates a stronger, lower-leverage balance sheet. See LPGO total equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Lipigon Pharmaceuticals AB (2017–2025)
Net asset quality index of Lipigon Pharmaceuticals AB from 2017 to 2025. This chart shows how Lipigon Pharmaceuticals AB's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the index stands at 68.9%, representing net assets of Skr7.91 Million against total assets of Skr11.49 Million SEK. Check asset allocation strategy of Lipigon Pharmaceuticals AB to assess the company's strategic physical and investment asset allocation.
Lipigon Pharmaceuticals AB Net Asset Quality Index by Year (2017–2025)
Lipigon Pharmaceuticals AB net asset quality index by year from 2017 to 2025. The table below presents the year-by-year Net Asset Quality Index for Lipigon Pharmaceuticals AB from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Lipigon Pharmaceuticals AB.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 68.9% | Skr7.91 Million | Skr11.49 Million | Skr3.57 Million | ▲ +16.5 pp |
| 2024 | 52.4% | Skr7.76 Million | Skr14.82 Million | Skr7.06 Million | ▼ -32.3 pp |
| 2023 | 84.6% | Skr28.44 Million | Skr33.60 Million | Skr5.16 Million | ▲ +48.9 pp |
| 2022 | 35.8% | Skr3.87 Million | Skr10.82 Million | Skr6.95 Million | ▼ -42.2 pp |
| 2021 | 78.0% | Skr22.96 Million | Skr29.43 Million | Skr6.47 Million | ▼ -7.2 pp |
| 2020 | 85.2% | Skr12.98 Million | Skr15.24 Million | Skr2.26 Million | ▲ +17.6 pp |
| 2019 | 67.6% | Skr2.17 Million | Skr3.21 Million | Skr1.04 Million | ▲ +441.8 pp |
| 2018 | -374.2% | Skr-842.00K | Skr225.00K | Skr1.07 Million | ▼ -439.2 pp |
| 2017 | 65.0% | Skr1.15 Billion | Skr1.77 Billion | Skr619.85 Million | — |